GOODMAN COREY S — SEC Form 4 filings
SEC reporting owner CIK 1278411. 5 Form 4 filings on record with FilingPulse; latest filed 2026-02-04.
Transaction summary — filings shown
Covers all 5 filings on record, filed 2024-06-14 to 2026-02-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 3,601,379 shares, $9,999,991 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 8.
- Largest priced transaction: purchase of 3,184,713 shares @ $1.57 ($4,999,999) in ALX ONCOLOGY HOLDINGS INC, filed 2026-02-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | Director, 10% owner | 4 | 1 leg · 3,184,713 sh · $4,999,999 | — | 3 |
| Artiva Biotherapeutics, Inc. (ARTV) | 10% owner | 1 | 1 leg · 416,666 sh · $4,999,992 | — | 5 |
Form 4 filings — GOODMAN COREY S
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-04 | 4 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Purchase (P): 3,184,713 @ $1.57 | EDGAR |
| 2026-01-21 | 4 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Grant/award (A): 40,400 (derivative) @ $0 | EDGAR |
| 2025-01-23 | 4 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Grant/award (A): 40,400 (derivative) @ $0 | EDGAR |
| 2024-07-22 | 4 | Artiva Biotherapeutics, Inc. (ARTV) jointly with venBio Global Strategic Fund III, L.P., VENBIO GLOBAL STRATEGIC GP III, L.P., VENBIO GLOBAL STRATEGIC GP III, LTD, Adelman Robert J | Conversion (C): 843,592 · Conversion (C): 214,692 · Other (J): 461,687 · Purchase (P): 416,666 @ $12 · Conversion (C): 843,592 (derivative) · Conversion (C): 214,692 (derivative) | EDGAR |
| 2024-06-14 | 4 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Grant/award (A): 20,200 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1278411 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →